Jun Yin

2.7k total citations
77 papers, 887 citations indexed

About

Jun Yin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jun Yin has authored 77 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jun Yin's work include Acute Lymphoblastic Leukemia research (12 papers), Cancer Genomics and Diagnostics (9 papers) and Statistical Methods in Clinical Trials (9 papers). Jun Yin is often cited by papers focused on Acute Lymphoblastic Leukemia research (12 papers), Cancer Genomics and Diagnostics (9 papers) and Statistical Methods in Clinical Trials (9 papers). Jun Yin collaborates with scholars based in United States, France and Italy. Jun Yin's co-authors include Dana B. Mukamel, Yue Li, Xueya Cai, Sumithra J. Mandrekar, Laurent G. Glance, Eli N. Perencevich, Ying Yuan, Marin L. Schweizer, Daniel J. Sargent and Richard M. Stone and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jun Yin

71 papers receiving 867 citations

Peers

Countries citing papers authored by Jun Yin

Since Specialization

Citations

This map shows the geographic impact of Jun Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Yin more than expected).

Fields of papers citing papers by Jun Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Yin. The network helps show where Jun Yin may publish in the future.

Co-authorship network of co-authors of Jun Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Yin. A scholar is included among the top collaborators of Jun Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Yin. Jun Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Narrative Review of the Use of Genomic-Adjusted Radiation Dose (GARD) in Radiotherapy 2025 ·Cancers ·Jun Yin	0
2	Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma 2024 ·Blood Advances ·Sarah C. Rutherford, Jun Yin, Levi Pederson, Kristie A. Blum, Peter Martin, Sin‐Ho Jung, Barbara Grant, Cara A. Rosenbaum, Bruce D. Cheson, Nancy L. Bartlett, Sumithra J. Mandrekar, John P. Leonard	2
3	GALAD Score for the Diagnosis of Hepatocellular Carcinoma in Sub-Saharan Africa: A Validation Study in Ghanaian Patients 2024 ·Cancer Research Communications ·Yvonne Ayerki Nartey, Ju Dong Yang, Tyler Zemla, (unknown), Shadrack Osei Asibey, Mohamed El‐Kassas, (unknown), Amoako Duah, Adwoa Agyei‐Nkansah, Yaw Asante Awuku, Mary Afihene, (unknown), Jun Yin, Amelie Plymoth, Lewis R. Roberts	2
4	Incidence and Long-Term Outcomes of Biliary Tract Cancers in Olmsted County, Minnesota from 1976 to 2018 2024 ·Cancers ·(unknown), (unknown), (unknown), Ju Dong Yang, (unknown), (unknown), Joseph J. Larson, Jun Yin, Gregory J. Gores, Sean P. Cleary, Lewis R. Roberts	2
5	SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma 2024 ·Cancers ·Andréa Martini, (unknown), Tyler Zemla, Fowsiyo Ahmed, (unknown), Nasra H. Giama, Vincenza Guzzardo, Alessandra Biasiolo, Matteo Fassan, Jun Yin, Patrizia Pontisso, Lewis R. Roberts	2
6	Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States 2023 ·Cancers ·Amro M. Abdelrahman, Jun Yin, (unknown), Jennifer A. Yonkus, Jennifer L. Leiting, (unknown), (unknown), (unknown), (unknown), Lewis R. Roberts, Gregory J. Gores, Rory L. Smoot, Rondell P. Graham, Þorvarður R. Hálfdánarson, Mark J. Truty	1
7	The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth 2023 ·Cells ·Kishor Pant, (unknown), Estanislao Peixoto, Jun Yin, Davis Seelig, Pietro Carotenuto, Massimiliano Salati, Brunella Franco, Lewis R. Roberts, Sergio A. Gradilone	10
8	Trajectories of body weight change and survival among patients with mCRC treated with systemic therapy: Pooled analysis from the ARCAD database 2022 ·European Journal of Cancer ·Jan Franko, Jun Yin, Richard Adams, John Zalcberg, (unknown), Eric Van Cutsem, Richard M. Goldberg, Herbert I. Hurwitz, Carsten Bokemeyer, Fairooz F. Kabbinavar, (unknown), (unknown), Benoist Chibaudel, Takayuki Yoshino, Aimery de Gramont, Qian Shi	3
9	Challenges, opportunities, and innovative statistical designs for precision oncology trials 2022 ·Annals of Translational Medicine ·Jun Yin, Shihao Shen, Qian Shi	4
10	Hierarchical Bayesian clustering design of multiple biomarker subgroups (HCOMBS) 2021 ·Statistics in Medicine ·(unknown), Christopher S. Coffey, Bruce A. Smith, Ying Yuan, Qian Shi, Jun Yin	5
11	phase1RMD: An R package for repeated measures dose-finding designs with novel toxicity and efficacy endpoints 2021 ·PLoS ONE ·Jun Yin, (unknown), Rui Qin, Shihao Shen, Sumithra J. Mandrekar	2
12	Morphological heterogeneity in beta-catenin–mutated hepatocellular carcinomas: implications for tumor molecular classification 2021 ·Human Pathology ·Michael Torbenson, (unknown), Daniel R. O’Brien, Jun Yin, (unknown), Nguyen H. Tran, Saba Yasir, (unknown), Renumathy Dhanasekaran, Keun Soo Ahn, Lewis R. Roberts, Chen Wang	14
13	Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling 2021 ·Cell Reports ·Hao Wang, Wei Hou, (unknown), (unknown), Jordan R. Beach, Xianzhong Ding, Jun Li, Mitchell F. Denning, (unknown), Scott J. Cotler, Cara Joyce, Jun Yin, Fowsiyo Ahmed, Lewis R. Roberts, Wei Qiu	33
14	Implementation and effectiveness of an intensive education program on phosphate control among hemodialysis patients: a non-randomized, single-arm, single-center trial 2021 ·BMC Nephrology ·(unknown), Jun Yin, (unknown), (unknown), Jing Zheng	6
15	Threshold Change in CEA as a Predictor of Non-Progression to First-Line Systemic Therapy in Metastatic Colorectal Cancer Patients With Elevated CEA 2020 ·JNCI Journal of the National Cancer Institute ·Pat Gulhati, Jun Yin, Levi Pederson, Hans‐Joachim Schmoll, Paulo M. Hoff, Jean‐Yves Douillard, J. Randolph Hecht, Christophe Tournigand, (unknown), Benoist Chibaudel, Aimery de Gramont, Qian Shi, Michael J. Overman	24
16	Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database 2020 ·Annals of Oncology ·Mohamed E. Salem, Jun Yin, Richard M. Goldberg, Levi Pederson, Norman Wolmark, Steven R. Alberts, Julien Taı̈eb, J. L. Marshall, Sara Lonardi, Takayuki Yoshino, Rachel Kerr, Greg Yothers, Axel Grothey, Thierry André, Aimery de Gramont, Qian Shi	17
17	Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination 2020 ·Pancreatology ·Ryan M. Carr, Narjust Duma, Angela L. McCleary‐Wheeler, Luciana L. Almada, David L. Marks, Rondell P. Graham, Thomas C. Smyrk, Val J. Lowe, Mitesh J. Borad, George Kim, Geoffrey B. Johnson, Jacob B. Allred, Jun Yin, (unknown), Tanios Bekaii‐Saab, (unknown), Charles Erlichman, Alex A. Adjei, Martín E. Fernández-Zapico	17
18	A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer 2019 ·Thyroid ·Ashish V. Chintakuntlawar, Jun Yin, Robert L. Foote, Jan L. Kasperbauer, Michael Rivera, Erik Asmus, (unknown), Jeffrey R. Janus, Minetta C. Liu, J. Daniel, Eric J. Moore, John C. Morris, M.A. Neben-Wittich, Daniel L. Price, Katharine A. Price, Mabel Ryder, Kathryn M. Van Abel, Crystal Hilger, (unknown), Keith C. Bible	57
19	Challenges encountered and lessons learned during a trial of an electronic hand hygiene monitoring system 2019 ·American Journal of Infection Control ·John M. Boyce, Timothea Cooper, Jun Yin, Fangyong Li, James W. Arbogast	20
20	Comprehensive survey of hand hygiene measurement and improvement practices in the Veterans Health Administration 2013 ·American Journal of Infection Control ·Heather Schacht Reisinger, Jun Yin, Lewis J. Radonovich, (unknown), Richard A. Martinello, Michael J. Hodgson, Eli N. Perencevich	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact